Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-15 06:11 am Purchase | 2025-10-07 | 13G | Zenas BioPharma, Inc. ZBIO | InnoCare Pharma Inc. | 5,000,000 9.400% | 5,000,000 (New Position) | Filing History |
| 2025-10-14 5:29 pm Purchase | 2025-10-09 | 13D | Zenas BioPharma, Inc. ZBIO | Enavate Sciences GP, LLC | 3,919,159 7.300% | 3,919,159 (New Position) | Filing History |
| 2025-10-14 5:29 pm Purchase | 2025-10-09 | 13D | Zenas BioPharma, Inc. ZBIO | SR One Capital Management, LLC | 5,037,854 9.400% | 126,315 (+2.57%) | Filing History |
| 2025-10-14 09:35 am Purchase | 2025-10-09 | 13D | Zenas BioPharma, Inc. ZBIO | Longitude Capital Partners IV, LLC | 2,631,522 4.900% | 2,631,522 (New Position) | Filing History |
| 2025-10-09 5:15 pm Purchase | 2025-10-07 | 13D | Zenas BioPharma, Inc. ZBIO | Leon O. Moulder, Jr. | 2,594,662 4.800% | 496,016 (+23.64%) | Filing History |
| 2025-09-08 11:46 am Purchase | 2025-08-29 | 13G | Zenas BioPharma, Inc. ZBIO | FMR LLC | 4,644,279 11.000% | 1,320,745 (+39.74%) | Filing History |
| 2025-08-06 12:19 pm Purchase | 2025-06-30 | 13G | Zenas BioPharma, Inc. ZBIO | FMR LLC | 3,323,534 7.900% | 471,163 (+16.52%) | Filing History |
| 2025-06-06 4:10 pm Purchase | 2025-05-30 | 13D | Zenas BioPharma, Inc. ZBIO | Leon O. Moulder, Jr. | 2,098,646 5.000% | 2,098,646 (New Position) | Filing History |
| 2025-05-12 10:20 am Purchase | 2025-03-31 | 13G | Zenas BioPharma, Inc. ZBIO | FMR LLC | 2,852,371 6.800% | 852,371 (+42.62%) | Filing History |
| 2025-04-01 9:47 pm Purchase | 2025-03-25 | 13G | Zenas BioPharma, Inc. ZBIO | Novo Holdings A/S | 2,214,967 5.300% | 2,214,967 (New Position) | Filing History |
| 2024-11-12 10:40 am Purchase | 2024-11-08 | 13G | Zenas BioPharma, Inc. ZBIO | FMR LLC | 2,000,000 5.026% | 2,000,000 (New Position) | Filing History |
| 2024-10-21 4:18 pm Purchase | 2024-09-16 | 13G | Zenas BioPharma, Inc. ZBIO | Xencor Inc XNCR | 3,098,380 7.400% | 3,098,380 (New Position) | Filing History |
| 2024-09-25 6:00 pm Purchase | 2024-09-16 | 13G | Zenas BioPharma, Inc. ZBIO | NEA 18 Venture Growth Equity L.P. | 2,613,948 6.600% | 2,613,948 (New Position) | Filing History |
| 2024-09-23 8:56 pm Purchase | 2024-09-16 | 13D | Zenas BioPharma, Inc. ZBIO | SR One Capital Management, LLC | 4,911,539 12.300% | 4,911,539 (New Position) | Filing History |
| 2024-09-23 8:11 pm Purchase | 2024-09-16 | 13D | Bicara Therapeutics Inc. Common Stock BCAX | Longitude Capital Partners IV, LLC | 2,501,934 6.000% | 2,501,934 (New Position) | Filing History |
| 2024-09-23 4:16 pm Purchase | 2024-09-16 | 13D | Bicara Therapeutics Inc. Common Stock BCAX | Enavate Sciences GP, LLC | 3,761,359 9.000% | 3,761,359 (New Position) | Filing History |